World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
52889
World Ranking
13844
National Ranking
7028

Research.com Recognitions

  • 2012 - Member of the National Academy of Medicine (NAM)
  • 1987 - Fellow of the American Statistical Association (ASA)

Overview

Thomas R. Fleming is affiliated with the University of Washington in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in Infectious Diseases, Statistics and Probability, Economics and Econometrics, Health, and Oncology.

Their scholarly work addresses a range of topics including:

  • SARS-CoV-2 and COVID-19 Research
  • Statistical Methods in Clinical Trials
  • Vaccine Coverage and Hesitancy
  • Health Systems, Economic Evaluations, Quality of Life
  • COVID-19 Clinical Research Studies
  • Ethics in Clinical Research
  • Viral Infections and Outbreaks Research

Frequent collaboration partners for Thomas R. Fleming include:

  • Ira M. Longini
  • Philip R. Krause
  • Martha Nason
  • Ana María Henao-Restrepo
  • Ying Huang

Their research articles have been published notably in venues such as:

  • Clinical Trials
  • UNC Libraries
  • New England Journal of Medicine
  • The Lancet
  • Annals of Internal Medicine

Selected recent papers authored or coauthored by Thomas R. Fleming include:

  • Conducting Clinical Research During the COVID-19 Pandemic, 2020, JAMA
  • SARS-CoV-2 Variants and Vaccines, 2021, New England Journal of Medicine
  • COVID-19 vaccine trials should seek worthwhile efficacy, 2020, The Lancet
  • Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials, 2020, Annals of Internal Medicine
  • Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them, 2020, New England Journal of Medicine

Thomas R. Fleming has received recognition from professional bodies, including being named a Member of the National Academy of Medicine in 2012 and a Fellow of the American Statistical Association in 1987.

Best Publications

  • Prevention of HIV-1 Infection with Early Antiretroviral Therapy

    Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble

  • A multiple testing procedure for clinical trials.

    Peter C. O'Brien;Thomas R. Fleming

  • Sildenafil citrate therapy for pulmonary arterial hypertension.

    Nazzareno Galiè;Hossein A. Ghofrani;Adam Torbicki;Robyn J. Barst

  • Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

    Moertel Cg;Fleming Tr;Macdonald Js;Haller Dg

  • A class of rank test procedures for censored survival data

    David P. Harrington;Thomas R. Fleming

  • Martingale-based residuals for survival models

    Terry M. Therneau;Patricia M. Grambsch;Thomas R. Fleming

  • Targeted Anticytokine Therapy in Patients with Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)

    Douglas L. Mann;John J.V. McMurray;Milton Packer;Karl Swedberg

  • One-Sample Multiple Testing Procedure for Phase II Clinical Trials

    Thomas R. Fleming

  • Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report

    Charles G. Moertel;Thomas R. Fleming;John S. Macdonald;Daniel G. Haller

  • Prognosis in primary biliary cirrhosis: model for decision making.

    E R Dickson;P M Grambsch;T R Fleming;L D Fisher

  • Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

    J A Laurie;C G Moertel;T R Fleming;H S Wieand

  • Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis

    Russell H. Wiesner;Patricia M. Grambsch;E. Rolland Dickson;Jurgen Ludwig

  • Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension: A Randomized Trial

    Ge rald Simonneau;Lewis J. Rubin;Nazzareno Galie;Robyn J. Barst

  • High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.

    Charles G. Moertel;Thomas R. Fleming;Edward T. Creagan;Joseph Rubin

  • Estimating the proportion of treatment effect explained by a surrogate marker

    Danyu Lin;T. R. Fleming;V. De Gruttola

  • An Evaluation of the Carcinoembryonic Antigen (CEA) Test for Monitoring Patients With Resected Colon Cancer

    Charles G. Moertel;Thomas R. Fleming;John S. Macdonald;Daniel G. Haller

  • A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric Carcinoma: Fluorouracil vs Fluorouracil and Doxorubicin vs Fluorouracil, Doxorubicin, and Mitomycin

    Stephen A. Cullinan;Charles G. Moertel;Thomas R. Fleming;Joseph R. Rubin

  • Pediatric Pulmonary Hypertension

    D. Dunbar Ivy;Steven H. Abman;Robyn J. Barst;Rolf M.F. Berger

  • Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.

    Joan Kreiss;Elizabeth Ngugi;King Holmes;Jeckoniah Ndinya-Achola

  • Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.

    C G Leichman;T R Fleming;F M Muggia;C M Tangen

Frequent Co-Authors

David L. DeMets
David L. DeMets University of Wisconsin–Madison
Jean B. Nachega
Jean B. Nachega University of Pittsburgh
Stein Emil Vollset
Stein Emil Vollset University of Washington
Zulfiqar A Bhutta
Zulfiqar A Bhutta Aga Khan University
Bach Xuan Tran
Bach Xuan Tran Vietnam National University, Hanoi
Ferrán Catalá-López
Ferrán Catalá-López Instituto de Salud Carlos III
Juan Sanabria
Juan Sanabria Marshall University
Cyrus Cooper
Cyrus Cooper University of Southampton
Alan D. Lopez
Alan D. Lopez University of Melbourne
Ted R. Miller
Ted R. Miller Pacific Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to becoming a doctor is just one way to contribute to the healthcare field. Many students choose alternative pathways that offer rewarding careers and valuable skills. If you are interested in the operational side of medicine, consider a health care administration online degree. These programs can prepare you for leadership roles in hospitals, clinics, and public health organizations.

Advancing your education doesn’t have to break the bank. There are options for cheap mha programs that provide a cost-effective route to a master’s degree in healthcare administration. For those aiming at advanced practice, the cheapest online dnp programs help nurses expand their clinical expertise and impact patient outcomes.

Students also explore careers in pharmacy, a crucial branch of medicine. Enrolling in the best online pharmacy school can open up opportunities in clinical, research, and pharmaceutical industry settings. These alternatives give you flexibility, affordability, and a broad range of options for a meaningful medical career.

Best Scientists Citing Thomas R. Fleming

Trending Scientists

Recently Published Articles